GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neutra Corp (OTCPK:NTRR) » Definitions » YoY EBITDA Growth

Neutra (Neutra) YoY EBITDA Growth : 0.00% (As of Oct. 2023)


View and export this data going back to 2011. Start your Free Trial

What is Neutra YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Neutra's YoY EBITDA Growth for the quarter that ended in Oct. 2023 was 0.00%.

Neutra's EBITDA per Share for the three months ended in Oct. 2023 was $0.00.


Neutra YoY EBITDA Growth Historical Data

The historical data trend for Neutra's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neutra YoY EBITDA Growth Chart

Neutra Annual Data
Trend Jan14 Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -270.97 99.13 100.00 - -

Neutra Quarterly Data
Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Neutra YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Neutra's YoY EBITDA Growth for the fiscal year that ended in Jan. 2023 is calculated as:

YoY EBITDA Growth (A: Jan. 2023 )
=(EBITDA per Share (A: Jan. 2023 )-EBITDA per Share (A: Jan. 2022 ))/ | EBITDA per Share (A: Jan. 2022 ) |
=(-0--0)/ | -0 |
=N/A %

Neutra's YoY EBITDA Growth for the quarter that ended in Oct. 2023 is calculated as:

YoY EBITDA Growth (Q: Oct. 2023 )
=(EBITDA per Share (Q: Oct. 2023 )-EBITDA per Share (Q: Oct. 2022 )) / | EBITDA per Share (Q: Oct. 2022 )) |
=(-0--0)/ | -0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Neutra YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Neutra's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Neutra (Neutra) Business Description

Traded in Other Exchanges
N/A
Address
54 Sugar Creek Center Boulevard, Suite 200, Sugar Land, TX, USA, 77478
Neutra Corp is a development-stage company, which intends to market and participate in the nutraceutical space by bringing products derived from all natural and organic origins. Along with participating in the actual nutraceutical products, the company plans to research and bring new technology to the Nutraceutical space. Nutraceutical natural medicine is an alternative system that focuses on natural remedies and the body's vital ability to heal and maintain itself. It focuses on the areas of anti-aging, sleep disorders, pain management, and others. Geographically, all the activities are operated through the region of the United States.
Executives
Sydney Jim director, officer: CEO & Chairman 8875 HIDDEN RIVER PARKWAY, SUITE 300, TAMPA FL 34243